Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

13.36
Delayed Data
As of Aug 27
 +0.28 / +2.14%
Today’s Change
3.70
Today|||52-Week Range
17.83
+153.99%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close13.08
Today’s open13.23
Day’s range13.06 - 13.85
Volume181,691
Average volume (3 months)333,529
Market cap$238.6M
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.35

Competitors

 Today’s
change
Today’s
% change
NVLSNivalis Therapeutics...+0.05+0.32%
TBRATobira Therapeutics ...-0.36-2.64%
DRRXDURECT Corp+0.06+3.06%
GALEGalena Biopharma Inc0.000.00%
Data as of 3:59pm ET, 08/27/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
Chief Financial Officer, Secretary, CAO &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers